Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia - Sinués, B.; Gazulla, J.; Bernal, M.L.; Lanuza, J.; Fanlo, A.; Saenz, M.A.; Bartolome, M. (Mutation Research, 1995)
Keywords: Adolescent; Adult; Aged; Biological and medical sciences; Biotransformation; Carbamazepine - adverse effects; Carbamazepine - analogs & derivatives; Carbamazepine - blood; Carbamazepine - urine; Carbamazepine mutagenicity assay; Case-Control Studies; Cell Division - drug effects; Child; Chromosome Aberrations; Drug toxicity and drugs side effects treatment; Epilepsy; Epilepsy - drug therapy; Female; Humans; Male; Medical sciences; Micronucleus Tests; Middle Aged; Miscellaneous (drug allergy, mutagens, teratogens...); Mitotic Index - drug effects; Mutagenicity Tests - methods; Pharmacology. Drug treatments; Salmonella typhimurium - drug effects; Sister Chromatid Exchange; Statistics, Nonparametric; Trigeminal neuralgia; Trigeminal Neuralgia - drug therapy; Epilepsy; Carbamazepine mutagenicity assay; Trigeminal neuralgia; Chromosomal aberration; Human; Cell proliferation; Nervous system diseases; Mutagenicity testing; Toxicity; Sister chromatid exchange; Micronucleus; Neuralgia